Week in review: Inhaled steroids raise IOP, antioxidants appear safe in AMD patients, brolucizumab approved for DME
- Posted on: Jun 4 2022
- Leave a response
This week in the news, inhaled and intranasal steroids increase IOP, antioxidant supplements for AMD appear safer than beta-carotene, and the FDA approves brolucizumab for diabetic macular edema (DME).
Source: AAO
Posted in: Uncategorized
